Home

Alkem Laboratories Limited

NSE: ALKEM · Results Thu, 12 Nov, 2026

About Alkem Laboratories Limited

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti – infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.

Summary as recorded on Wed, 02 Sept, 2026.

Results

  • Financial ResultsThu, 12 Nov, 2026

Historical quarterly results aren't available in the current data feed.

Corporate Actions

No recent corporate actions for ALKEM.

Latest News · Alkem Laboratories Limited

Loading news…

Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.